This is the first in vivo human study to quantify the predictability of expansion in patients with Invisalign® Ex30 material.
Background The purpose of this study is to evaluate the efficacy and predictability of upper and lower orthodontic expansion with the Invisalign® system. Material and Methods From a sample of 167 patients; 64 upper and 51 lower arches were randomly selected from patients who had been treated with plastic orthodontics (Invisalign® aligners, SmartTrack® material). Digital models were extracted at the beginning (ModT1) and at the end of treatment (ModT2) as well as the final ClinCheck® (CkT2). The canine, premolar and molar width was measured at the gingival and cuspid level of both arches, as well as the inclination of the upper first molar. Likewise, both arches were divided regarding the planned expansion at the level of the first molar into mild, moderate and severe. Results The efficacy of expansion in the upper and lower arches showed a statistically significant difference ( p <0.00005). During the measurements of predictability, around 98-100% was achieved at the coronal level and between 85-90% at the gingival level. Analyzing predictability regarding to the magnitude of expansion, superior and inferior moderate expansion, both gingival and cuspid, presented higher values. Conclusions The Invisalign® system aligners (SmartTrack® material), proved to be a positive alternative for expansion movement offering high degree of predictability, both in the upper and lower arches. As a result, the most predictable level of expansion was moderate, having being the lower arch more foreseeable at the gingival level than the upper arch. Key words: Predictability, Efficacy, Expansion, Aligner, Invisalign®.
Purpose To evaluate the effectiveness of apexification versus revascularization in the treatment of necrotic immature teeth and determine which strategy affords the greatest radiological success rate. Methods An analysis was made of 18 teeth subjected to mineral trioxide aggregate (MTA) apical plugging and regenerative endodontic treatment, assessing healing of the apical lesions and the changes in root dimensions. Results Significantly greater root growth was observed with revascularization in terms of the percentage change in length (12.75% at 6 months) and dentin thickness (34.57% at 6 months) (p < 0.05). There were no significant differences between the two treatments in terms of the apical healing scores after 6 months of follow-up (p > 0.05). Conclusion Apexification with an MTA apical plug and pulp regeneration are reliable treatments for non-vital immature teeth. The radiographic outcomes are comparable between the immature teeth subjected to MTA apexification versus those subjected to revascularization. The results of the present study indicate a greater increase in root length and width with regenerative endodontic treatment.
Purpose: An update is provided on the different types of early treatment for class III malocclusions of maxillary origin. There is an increasing tendency to prescribe maxillary orthopedic treatment with skeletal an-chorage, with the purpose of enhancing the skeletal and reducing the dentoalveolar effects - offering a management option for children with important deformations that otherwise would have to wait until adult age to receive surgical treatment. Method: A literature review has been made of maxillary bone orthopedic traction appliances in growing children with class III malocclusions. A Medline (PubMed) search was made using the following MeSH terms: Cephalometric, Child, Malocclusion class III / therapy, Extraoral traction appliances, Palatal expansion, Bone plates, Skeletal anchorage, Orthodontic anchorage. Results: Many articles show that the greatest maxillary advances are obtained at very early ages, though with a greater tendency towards relapse. However, skeletal anchorage has been seen to afford a lesser relapse rate and greater dentofacial orthopedic efficiency due to its low dentoalveolar impact. In any case, further randomized clinical studies are needed to firmly establish the quantifiable differences in terms of maxillary advance, optimum traction age, optimum traction appliance and potential side effects. At present, the incorporation of surgically inserted bone anchorage appliances (miniplates and miniscrews) offers a purely orthopedic approach to treatment, with minimization of the undesirable side effects of traditional dentofacial orthopedic compensation based on dentoalveolar anchorage. Nevertheless, further studies are needed to consolidate the supporting scientific evidence in this field.
Aims: Ectopic eruption is a change in the normal path of eruption of a tooth. The aim of this study is to determine the prevalence of ectopic eruption of the permanent maxillary first molars in a Spanish subpopulation of 505 children, its distribution as regards age and gender, unilateral and bilateral occurrence and loss of space. Methods: Periapical and panoramic X-rays were taken of the patients, with six-monthly check-ups to evaluate development. A statistical analysis of the data was performed using the chi-square test (p lessthan 0.05, 95% C.I). Results: A prevalence of 6.7% was obtained being the most common age of presentation was seven years and bilateral occurrence (67.6% of cases) with no statistically significant differences as regards to the gender. Only 14 of the 505 explored patients required treatment for ectopic eruption. Conclusion: This study provides information regarding treatment needs and prevalence regarding molar ectopic eruption in a Spanish population. It is essential for professionals to be familiar with the diagnostic factors, clinical consequences and therapeutic options for ectopic eruption of permanent molars.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.